Document ID: chunk:federal_register_of_legislation:F2025L00216:schedule:1:p1
Version: federal_register_of_legislation:F2025L00216
Segment Type: schedule
Provision Reference: sch 1 (pt 1/2)
Character Range: 2171–5580

Schedule 1—Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

     1.            Schedule 1, after entry for Donepezil in the form Tablet containing donepezil hydrochloride 10 mg
insert:
Drospirenone with ethinylestradiol  Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets                         20  3  3
                                    Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol (as betadex clathrate) and 4 inert tablets  20  3  3

     1.            Schedule 1, after entry for Estradiol in the form Tablet containing estradiol valerate 2 mg
    insert:
   Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses  20  1  5

     1.            Schedule 1, after entry for Estradiol in the form Transdermal patches 1.56 mg, 8
         insert:
   Transdermal patches 1.56 mg, 24 (Sandoz) (S19A)  20  1  1

     1.            Schedule 1, after entry for Estradiol with norethisterone in the form Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8
insert:
   Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 (S19A)  20  1  5

     1.            Schedule 1, after entry for Estradiol with norethisterone in the form Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8
    insert:
   Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 (S19A)  20  1  5

     1.            Schedule 1, after entry for Probenecid
         insert:
Progesterone                Capsule 100 mg                                                                                                                                                    20  30  5
Progesterone and estradiol  Pack containing 30 capsules progesterone 100 mg (micronised) and transdermal gel (pump pack) estradiol 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses  20  1   5

     1.            Schedule 2, after entry for Acarbose in the form Tablet 50 mg
insert:
   Tablet 50 mg (S19A)  50  180  5

     1.            Schedule 2, after entry for Acarbose in the form Tablet 100 mg
insert:
   Tablet 100 mg (S19A)  50  180  5

     1.            Schedule 2, after entry for Doxycycline in the form Tablet 50 mg (as monohydrate)
    insert:
Duloxetine  Capsule 60 mg (as hydrochloride)  50  56  2

     1.        Schedule 2, after entry for Estradiol in the form Tablet containing estradiol valerate 2 mg
    insert:
   Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses  50  2  5

     1.        Schedule 2, after entry for Estradiol with norethisterone in the form Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8
insert:
   Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 (S19A)  50  2  5

     1.        Schedule 2, after entry for Estradiol with norethisterone in the form Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8
    insert:
   Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7